the market?
Perrigo Company
NASDAQ: PRGO
118.92
1.06
(0.90%)
| Today's Open | $117.35 |
|---|---|
| Previous Close | $117.86 |
| Daily Range | $116.67 - $119.13 |
| 52-Week Range | $98.79 - $121.33 |
| Market Cap | $11.2B |
| P/E Ratio | 25.85 |
| Dividend (Yield) | $0.36 (0.3%) |
| Ex-Dividend Date Dividend Pay Date |
05/29/13 06/18/13 |
| Volume | 403,796 |
| Average Daily Volume | 484,126 |
| Current FY EPS | $5.61 |
How do you think PRGO
will perform against the market?
Top PRGO Bull/Bear Pitches
News & Commentary
The New Generic-Drug Battle Front
One generic pharmaceutical company is determined to chance consumer habits.Perrigo Goes With $0.09 Quarterly Dividend
The company matches its previous distributionAbbVie Q1: Story of Humira and the 7 Dwarfs
AbbVie's Q1 results aren't a fairy tale, but the story is all about Humira and the "7 Dwarfs."How Will AbbVie's Earnings Fare?
The newly independent pharma company gives its report on Friday.Perrigo Closes Acquisition of Pet Health Products Company
The consumer health-care specialist broadens its product line.Will Testosterone Fuel Biotech's Next Great Race?
Can AbbVie's AndroGel hold on to the title of Mr. Macho in testosterone replacement therapies?Sector
Healthcare
Industry
Drugs
Perrigo Company (PRGO) Description
The Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. Website: http://www.perrigo.com/
CEO Rating by Glassdoor
More details for Perrigo Jobs
Perrigo reviews from employees
